AGRF Achieves Revvity NGS Certification for Small RNA Sequencing
/
AGRF is proud to announce that we have officially been recognised as a Revvity NGS Certified Lab for Small RNA sequencing.
Read More
Polygenic Risk Scores: A game-changer for disease prevention and personalised healthcare.
/
Polygenic Risk Scores (PRS) are transforming the way we predict, prevent, and manage common diseases like cancer, cardiovascular disease, and diabetes. By analysing thousands of genetic variants, PRS provides a powerful tool for identifying individuals at higher risk, enabling earlier interventions and more personalised healthcare strategies. Now, with the integration of Allelica PREDICT and AGRF’s high-quality genotyping services, researchers and clinicians have access to cutting-edge PRS analysis that strengthens primary care, enhances public health initiatives, and supports groundbreaking medical research.
Read MorePartnership to Drive Innovation in Genomic Science
/
An exciting partnership between AGRF (the Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.
The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.
Read MoreAGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies→
/
AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s Advanced Genomics group to offer cutting-edge epigenetic services utilising EpiCypher’s CUT&RUN and CUT&Tag technologies.
Read MoreAGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities
/
Media Release
AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. Funded by The Kids Research Institute (The Kids) in Perth, the platform joins our certified Olink Explore HT and Explore 3072 workflows and will allow us to run the Olink Target 96 and 48 workflows, enabling researchers with both absolute and relative quantitative proteomic data, driving the identification and validation of biomarkers from early discovery to implementation and disease risk prediction.
Read MoreAGRF achieves Olink® Certified Service Provider Status
/
AGRF are proud to announce its recent recognition as an Olink® Certified Service Provider.
Read MoreDovetail Genomics and AGRF Announce Transformative Partnership Set to Advance Genomic Research in Australasia
/
Collaboration Establishes AGRF as Premier Provider of Dovetail's Cutting-Edge Genomic Technologies, Boosting Innovation and Access Across Australia and New Zealand
Read MoreMilestone Achievement For Paediatric Cancer Research
/
In an exciting step forward for children’s cancer research, the Australian Cancer Research Foundation (ACRF) has awarded a $2 million grant to Children’s Cancer Institute. The grant will advance the initiation of their Spatial Immune-oncology Research program, aiming to unlock the potential of immunotherapies specifically tailored for childhood cancer. A key partnership with AGRF will introduce our Olink technology for in-depth protein analysis, unlocking new possibilities in paediatric cancer research.
Read MoreAGRF: Bringing Olink® Next Generation Proteomic Technology to Australia.
/
AGRF is thrilled to announce the introduction of the Olink Explore high throughput platform to our fleet of cutting-edge technologies, bringing the most advanced proteomic technology to Australia and positioning AGRF as a truly multi-omics destination. This strategic move promises to be a game changer in precision medicine, offering researchers a full multi-omics profile of patient and biobank samples.
Read MoreCongratulations Dr. Benjamin Nash: Winner of the 2023 PacBio Revio HiFi Sequencing Grant Opportunity
/
We are thrilled to announce that Dr Benjamin Nash has been named as the recipient of the 2023 PacBio ANZ Revio HiFi SMRT Grant! Ben’s project, titled “Precision medicine in inherited retinal dystrophies (IRDs) using long read sequencing.” has captured our attention and admiration and we are delighted to be working with Ben and his team.
Read More
